Claims for Patent: 7,659,112
✉ Email this page to a colleague
Summary for Patent: 7,659,112
Title: | Process for producing physiologically active protein using genetically modified silkworm |
Abstract: | The present invention provides a genetic engineering material for insects that enables a target protein to be purified easily, without requiring the use of recombinant baculovirus, while simultaneously providing a process for producing exogenous protein using that genetic engineering material. A gene recombinant silkworm is obtained by inserting an exogenous protein gene such as a cytokine gene coupled to a promoter that functions in silk glands into a silkworm chromosome. An exogenous protein such as a cytokine is then extracted and purified from the silk glands or cocoon of that silkworm or its offspring. A large amount of exogenous protein can be produced within silk gland cells, outside silk gland cells or in silk thread or a cocoon by inserting an expression gene cassette, in which the DNA sequence of the 3\' terminal portion and the DNA sequence of the 5\' terminal portion of fibroin H chain gene are fused to the exogenous protein gene, into silk gland cells and so forth. |
Inventor(s): | Hiramatsu; Shingo (Nagoya, JP), Tanaka; Takashi (Nagoya, JP), Yamada; Katsushige (Aichi, JP), Tamura; Toshiki (Ushiku, JP) |
Assignee: | Toray Industries, Inc. (Tokyo, JP) |
Application Number: | 10/506,327 |
Patent Claims: | 1. A gene cassette for expressing an exogenous protein comprising in order: (1) an inverted repetitive sequence of a piggyBac transposon; (2) an approximately 5500
base pair sequence consisting of nucleotides 1-5484 of SEQ ID NO:23; (3) an exogenous protein gene coupled downstream from (2); and (4) an inverted repetitive sequence of a piggyBac transposon.
2. A gene cassette for expressing an exogenous protein comprising in order: (1) an inverted repetitive sequence of a piggyBac transposon; (2) an approximately 5500 base pair sequence consisting of nucleotides 1-5484 of SEQ ID NO:23; (3) an exogenous protein gene not containing a stop codon coupled downstream from (2); (4) a 3' terminal portion of the fibroin H chain gene fused to the 3' side of an exogenous protein structural gene; and (5) an inverted repetitive sequence of a piggyBac transposon. 3. The gene cassette according to claim 1 or claim 2, wherein the 5' terminal portion of the fibroin H chain gene contains a first exon, first intron and a portion of a second exon of the fibroin H chain gene. 4. The gene cassette according to claim 3, wherein the upstream region, the promoter and the 5' terminal portion together comprise the DNA as shown in SEQ ID NO: 23. 5. The gene cassette according to claim 2, wherein the 3' terminal portion of the fibroin H chain gene contains at least one codon that encodes cysteine. 6. The gene cassette according to claim 5, wherein the 3' terminal portion of the fibroin H chain gene consists of the DNA shown in SEQ ID NO: 24. 7. The gene cassette according to claims 1 or 2, wherein a poly A addition region of fibroin H chain gene is present downstream from the gene cassette. 8. A gene cassette for inserting a gene into chromosomes of insect cells comprising inverted repetitive sequences of a pair of piggyBac transposons present on both sides of the gene cassette according to claims 1 or 2. 9. An expression vector for insect cells that contains the gene cassette according to claims 1 or 2. 10. A gene insertion vector for insect cells that contains the gene cassette of claim 8 for inserting a gene into chromosomes of insect cells. 11. A process for producing an exogenous protein comprising inserting the vector for insect cells according to claim 9 into insect cells. 12. The process for producing an exogenous protein according to claim 11, wherein the insect cells originate in a lepidopteron. 13. The process for producing the exogenous protein according to claim 12, wherein the insect cells originate in Bombyx mori. 14. The process for producing an exogenous protein according to claim 13, wherein the insect cells are silk gland cells of Bombyx mori. 15. A process for producing an exogenous protein comprising producing a recombinant silkworm in which the gene cassette according to claims 1 or 2 is inserted into a chromosome using a gene insertion vector for insect cells and the DNA transfer activity of piggyBac transposase, producing exogenous protein in the silk glands or cocoon and silk thread of the resulting recombinant silkworm, recovering the exogenous protein from the silk glands or silk and cocoon thread in an aqeous solution. 16. The process for producing an exogenous protein according to claim 15, wherein the recombinant silkworm, in which the gene cassette for expressing an exogenous protein has been inserted into a chromosome, is produced by simultaneously micro-injecting the gene insertion vector for insect cells and DNA or RNA that produces the piggyBac transposase into silkworm eggs. 17. A process for producing an exogenous protein comprising inserting the vector for insect cells according to claim 10 into insect cells. 18. The process for producing an exogenous protein according to claim 17, wherein the insect cells originate in a lepidopteron. 19. The process for producing the exogenous protein according to claim 18, wherein the insect cells originate in Bombyx mori. 20. The process for producing an exogenous protein according to claim 19, wherein the insect cells are silk gland cells of Bombyx mori. |
Details for Patent 7,659,112
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
---|---|---|---|---|---|---|---|
Merck Sharp & Dohme Corp. | INTRON A | interferon alfa-2b | For Injection | 103132 | 06/04/1986 | ⤷ Try a Trial | 2022-03-06 |
Merck Sharp & Dohme Corp. | INTRON A | interferon alfa-2b | For Injection | 103132 | ⤷ Try a Trial | 2022-03-06 | |
Merck Sharp & Dohme Corp. | INTRON A | interferon alfa-2b | Injection | 103132 | ⤷ Try a Trial | 2022-03-06 | |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.